Large Language Models in Drug Discovery: A Survey

03 October 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Drug Discovery is a very lengthy and resource-consuming process. However, a variety of advanced Artificial Intelligence (AI) and Deep Learning (DL) techniques are being utilized to accelerate and advance DD, such as Large Language Models (LLMs). This survey is in aim of discovering and comparing the currently available LLMs, their methodologies, used datasets, and the different tasks they are aiding in in the DD process, in particular; de novo drug design, drugtarget interaction prediction, masked language models, variational auto encoders, binding affinity prediction, drug repurposing, molecular optimization, activity prediction, contrastive learning for drug-target interaction prediction, and other miscellaneous models. This survey gives insights into future directions and potential in this area.

Keywords

Large Language Model
Drug Discovery
Drug-Target Interaction
Contrastive Learning
Highthroughput in-Silico Screening
Transformer
Computational Chemistry

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.